Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 12, 2013
Fusion-activated cation entry (FACE) via P2X₄ couples surfactant secretion and alveolar fluid transport
Kristin E Thompson, Jonas P Korbmacher, Elena Hecht, et al.
Biomedicines
|
January 28, 2026
In Vitro and In Vivo Efficacy of Epithelial Barrier-Promoting Barriolides as Potential Therapy for Ulcerative Colitis
Jon P Joelsson, Michael J Parnham, Laurène Froment, et al.
Angiogenesis
|
July 4, 2018
Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro
Soheila Zeinali, Colette A Bichsel, Nina Hobi, et al.
Biofabrication
|
December 17, 2025
Microengineered alveolar array lung-on-chip with hydrogel membrane and simulated breathing mechanics for anti-fibrotic testing
Tobias Weber, Pauline Zamprogno, Sabine Schneider, et al.
Biochimica Et Biophysica Acta
|
May 8, 2016
A small key unlocks a heavy door: The essential function of the small hydrophobic proteins SP-B and SP-C to trigger adsorption of pulmonary surfactant lamellar bodies
Nina Hobi, Michael Giolai, Bárbara Olmeda, et al.
Frontiers in Medicine
|
May 24, 2021
Human-Based Advanced <i>in vitro</i> Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
Mirjam Kiener, Nuria Roldan, Carlos Machahua, et al.
Archives of Toxicology
|
January 14, 2026
Breathing lung-on-chip: a versatile tool for assessing respiratory toxicity across multiple therapeutic modalities
Linnea Johansson, Giulia Raggi, James Cartwright, et al.
Respiratory Research
|
January 30, 2020
Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
Kristina Krempaska, Sandra Barnowski, Jacopo Gavini, et al.
Respiratory Research
|
January 17, 2020
Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected]
Kristina Krempaska, Sandra Barnowski, Jacopo Gavini, et al.
Scientific Reports
|
September 27, 2018
Medium throughput breathing human primary cell alveolus-on-chip model
Janick D Stucki, Nina Hobi, Artur Galimov, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 12, 2013
Fusion-activated cation entry (FACE) via P2X₄ couples surfactant secretion and alveolar fluid transport
Kristin E Thompson, Jonas P Korbmacher, Elena Hecht, et al.
Biomedicines
|
January 28, 2026
In Vitro and In Vivo Efficacy of Epithelial Barrier-Promoting Barriolides as Potential Therapy for Ulcerative Colitis
Jon P Joelsson, Michael J Parnham, Laurène Froment, et al.
Angiogenesis
|
July 4, 2018
Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro
Soheila Zeinali, Colette A Bichsel, Nina Hobi, et al.
Biofabrication
|
December 17, 2025
Microengineered alveolar array lung-on-chip with hydrogel membrane and simulated breathing mechanics for anti-fibrotic testing
Tobias Weber, Pauline Zamprogno, Sabine Schneider, et al.
Biochimica Et Biophysica Acta
|
May 8, 2016
A small key unlocks a heavy door: The essential function of the small hydrophobic proteins SP-B and SP-C to trigger adsorption of pulmonary surfactant lamellar bodies
Nina Hobi, Michael Giolai, Bárbara Olmeda, et al.
Frontiers in Medicine
|
May 24, 2021
Human-Based Advanced <i>in vitro</i> Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
Mirjam Kiener, Nuria Roldan, Carlos Machahua, et al.
Archives of Toxicology
|
January 14, 2026
Breathing lung-on-chip: a versatile tool for assessing respiratory toxicity across multiple therapeutic modalities
Linnea Johansson, Giulia Raggi, James Cartwright, et al.
Respiratory Research
|
January 30, 2020
Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
Kristina Krempaska, Sandra Barnowski, Jacopo Gavini, et al.
Respiratory Research
|
January 17, 2020
Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected]
Kristina Krempaska, Sandra Barnowski, Jacopo Gavini, et al.
Scientific Reports
|
September 27, 2018
Medium throughput breathing human primary cell alveolus-on-chip model
Janick D Stucki, Nina Hobi, Artur Galimov, et al.
Page
of 3